Yunping Luo Selected Research

Yunping Luo Research Topics

Disease

43	Neoplasms (Cancer) 03/2024 - 05/2003
21	Breast Neoplasms (Breast Cancer) 10/2023 - 07/2003
14	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2003
5	Carcinoma (Carcinomatosis) 04/2008 - 05/2003
4	Lung Neoplasms (Lung Cancer) 03/2024 - 04/2005
4	Infections 02/2022 - 12/2006
4	Inflammation (Inflammations) 01/2021 - 10/2015
2	Communicable Diseases (Infectious Diseases) 02/2022 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 11/2016 - 06/2013
2	Melanoma (Melanoma, Malignant) 04/2008 - 06/2004
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 02/2022
1	COVID-19 02/2022
1	Carcinogenesis 01/2021
1	Disease Progression 01/2020
1	Lymphatic Metastasis 01/2019
1	Hypersensitivity (Allergy) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Hepatitis 11/2015
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2015
1	Necrosis 06/2009

Drug/Important Bio-Agent (IBA)

15	VaccinesIBA 02/2022 - 05/2003
12	DNA VaccinesIBA 09/2011 - 05/2003
7	Small Interfering RNA (siRNA)IBA 01/2021 - 02/2013
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2006
5	asparaginylendopeptidase (legumain)IBA 12/2011 - 01/2006
4	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2016
4	Transcription Factors (Transcription Factor)IBA 11/2014 - 07/2003
4	LigandsIBA 12/2011 - 08/2005
4	AutoantigensIBA 04/2008 - 06/2004
3	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2021
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2023 - 09/2005
3	CateninsIBA 01/2021 - 11/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2015 - 08/2006
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2011 - 01/2006
3	DNA (Deoxyribonucleic Acid)IBA 04/2008 - 05/2003
3	A-Form DNA (A-DNA)IBA 04/2005 - 07/2003
2	EnzymesIBA 03/2024 - 01/2021
2	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2022 - 02/2010
2	Vaccine AdjuvantsIBA 02/2022 - 01/2019
2	Cancer VaccinesIBA 01/2021 - 09/2011
2	Cadherins (E-Cadherin)IBA 01/2021 - 11/2014
2	Estrogen ReceptorsIBA 01/2021 - 01/2019
2	CytokinesIBA 11/2020 - 12/2018
2	Intercellular Adhesion Molecule-3IBA 08/2018 - 01/2018
2	AntigensIBA 09/2011 - 04/2008
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2009 - 05/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2009 - 08/2006
2	Peptide Hydrolases (Proteases)FDA Link 04/2008 - 01/2006
2	SurvivinIBA 04/2006 - 01/2005
2	Interleukin-18 (Interleukin 18)IBA 04/2005 - 07/2003
2	fos-related antigen 1IBA 04/2005 - 07/2003
1	Carnitine (L-Carnitine)FDA LinkGeneric 03/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2024
1	TransferasesIBA 03/2024
1	Chimeric Antigen ReceptorsIBA 10/2023
1	OligodeoxyribonucleotidesIBA 05/2022
1	Toll-Like Receptor AgonistsIBA 02/2022
1	XAV939IBA 01/2021
1	AntibodiesIBA 01/2021
1	Lactate Dehydrogenase 5IBA 01/2021
1	statticIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	AgarIBA 01/2020
1	Cilostazol (Pletal)FDA LinkGeneric 01/2020
1	Type 3 Cyclic Nucleotide PhosphodiesterasesIBA 01/2020
1	Aldehyde DehydrogenaseIBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 12/2018
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2018
1	AntagomirsIBA 12/2018
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 08/2018
1	lifitegrastIBA 08/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2017
1	JNK Mitogen-Activated Protein KinasesIBA 11/2015
1	GalactosamineIBA 11/2015
1	LipopolysaccharidesIBA 11/2015
1	Thiostrepton (Gargon)IBA 10/2015
1	Imiquimod (Aldara)FDA LinkGeneric 10/2015
1	I-kappa B KinaseIBA 04/2015
1	Antineoplastic Agents (Antineoplastics)IBA 06/2014
1	ErbB Receptors (EGF Receptor)IBA 02/2013
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 12/2011
1	1- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazoleIBA 09/2011
1	Beclin-1IBA 08/2011
1	Interleukin-7 (Interleukin 7)IBA 11/2009
1	Messenger RNA (mRNA)IBA 11/2009
1	Interleukin-2 (IL2)IBA 11/2009
1	Interleukin-1 (Interleukin 1)IBA 06/2009
1	Histocompatibility Antigens Class IIBA 04/2008
1	Cystine (L-Cystine)IBA 04/2008
1	EpitopesIBA 04/2008
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 12/2006

Therapy/Procedure

15	Therapeutics 03/2024 - 01/2006
4	Immunotherapy 03/2024 - 01/2021
2	Drug Therapy (Chemotherapy) 06/2013 - 12/2006
1	Immunomodulation 10/2023